Contemporary Update on the Microbiology of Paranasal Sinusitis
Abstract
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Cho, D.-Y.; Hunter, R.C.; Ramakrishnan, V.R. The Microbiome and Chronic Rhinosinusitis. Immunol. Allergy Clin. N. Am. 2020, 40, 251–263. [Google Scholar] [CrossRef]
- Biswas, K.; Hoggard, M.; Jain, R.; Taylor, M.W.; Douglas, R.G. The nasal microbiota in health and disease: Variation within and between subjects. Front. Microbiol. 2015, 9, 134. [Google Scholar] [CrossRef] [PubMed]
- Proctor, D.M.; Relman, D.A. The Landscape Ecology and Microbiota of the Human Nose, Mouth, and Throat. Cell Host Microbe 2017, 21, 421–432. [Google Scholar] [CrossRef] [PubMed]
- Aurora, R.; Chatterjee, D.; Hentzleman, J.; Prasad, G.; Sindwani, R.; Sanford, T. Contrasting the Microbiomes from Healthy Volunteers and Patients with Chronic Rhinosinusitis. JAMA Otolaryngol.–Head Neck Surg. 2013, 139, 1328. [Google Scholar] [CrossRef]
- Mahdavinia, M.; Keshavarzian, A.; Tobin, M.C.; Landay, A.L.; Schleimer, R.P. A comprehensive review of the nasal microbiome in chronic rhinosinusitis (CRS). Clin. Exp. Allergy 2016, 46, 21–41. [Google Scholar] [CrossRef] [PubMed]
- Ramakrishnan, V.R.; Feazel, L.M.; Gitomer, S.A.; Ir, D.; Robertson, C.E.; Frank, D.N. The Microbiome of the Middle Meatus in Healthy Adults. PLoS ONE 2013, 8, e85507. [Google Scholar] [CrossRef] [PubMed]
- Bhattacharyya, N. The Microbiology of Recurrent Rhinosinusitis after Endoscopic Sinus Surgery. Arch. Otolaryngol. Head Neck Surg. 1999, 125, 1117. [Google Scholar] [CrossRef] [PubMed]
- Bhattacharyya, N.; Gopal, H.V. Microbiology of the ethmoid sinus following endoscopic sinus surgery. Ear Nose Throat J. 2002, 81, 458–461. [Google Scholar] [CrossRef] [PubMed]
- Mackenzie, B.W.; Waite, D.W.; Hoggard, M.; Douglas, R.G.; Taylor, M.W.; Biswas, K. Bacterial community collapse: A meta-analysis of the sinonasal microbiota in chronic rhinosinusitis. Environ. Microbiol. 2017, 19, 381–392. [Google Scholar] [CrossRef]
- Chalermwatanachai, T.; Vilchez-Vargas, R.; Holtappels, G.; Lacoere, T.; Jáuregui, R.; Kerckhof, F.-M.; Pieper, D.H.; Van de Wiele, T.; Vaneechoutte, M.; Van Zele, T.; et al. Chronic rhinosinusitis with nasal polyps is characterized by dysbacteriosis of the nasal microbiota. Sci. Rep. 2018, 8, 7926. [Google Scholar] [CrossRef]
- Lee, J.T.; Frank, D.N.; Ramakrishnan, V. Microbiome of the Paranasal Sinuses: Update and Literature Review. Am. J. Rhinol. Allergy 2016, 30, 3–16. [Google Scholar] [CrossRef] [PubMed]
- Abreu, N.A.; Nagalingam, N.A.; Song, Y.; Roediger, F.C.; Pletcher, S.D.; Goldberg, A.N.; Lynch, S.V. Sinus Microbiome Diversity Depletion and Corynebacterium tuberculostearicum Enrichment Mediates Rhinosinusitis. Sci. Transl. Med. 2012, 4, 151ra124. [Google Scholar] [CrossRef] [PubMed]
- Ramakrishnan, V.R.; Hauser, L.J.; Feazel, L.M.; Ir, D.; Robertson, C.E.; Frank, D.N. Sinus microbiota varies among chronic rhinosinusitis phenotypes and predicts surgical outcome. J. Allergy Clin. Immunol. 2015, 136, 334–342.e1. [Google Scholar] [CrossRef] [PubMed]
- Marple, B.F.; Stankiewicz, J.A.; Baroody, F.M.; Chow, J.M.; Conley, D.B.; Corey, J.P.; Ferguson, B.J.; Kern, R.C.; Lusk, R.P.; Naclerio, R.M.; et al. Diagnosis and Management of Chronic Rhinosinusitis in Adults. Postgrad. Med. 2009, 121, 121–139. [Google Scholar] [CrossRef] [PubMed]
- Fokkens, W.J.; Lund, V.I.; Mullol, J.; Bachert, C.; Alobid, I.; Baroody, F.; Wormald, P.J. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinology 2012, 23, 1–298. [Google Scholar]
- Orlandi, R.R.; Kingdom, T.T.; Smith, T.L.; Bleier, B.; DeConde, A.; Luong, A.U.; Poetker, D.M.; Soler, Z.; Welch, K.C.; Wise, S.K.; et al. International consensus statement on allergy and rhinology: Rhinosinusitis 2021. Int. Forum Allergy Rhinol. 2021, 11, 213–739. [Google Scholar] [PubMed]
- Bhattacharyya, N.; Gopal, H.V.; Lee, K.H. Bacterial Infection After Endoscopic Sinus Surgery: A Controlled Prospective Study. Laryngoscope 2004, 114, 765–767. [Google Scholar] [CrossRef] [PubMed]
- Jiang, Z.Y.; Kou, Y.-F.; Batra, P.S. Endoscopic culture-directed antibiotic therapy: Impact on patient symptoms in chronic rhinosinusitis. Am. J. Otolaryngol. 2015, 36, 642–646. [Google Scholar] [CrossRef]
- Miller, C.; Davis, G.E. Are multiple sinus cultures necessary during sinus surgery for chronic rhinosinusitis? Int. Forum Allergy Rhinol. 2018, 8, 504–508. [Google Scholar] [CrossRef]
- Hansen, S.K.; Rau, M.H.; Johansen, H.K.; Ciofu, O.; Jelsbak, L.; Yang, L.; Folkesson, A.; Jarmer, H.; Aanæs, K.; von Buchwald, C.; et al. Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection. ISME J. 2012, 6, 31–45. [Google Scholar] [CrossRef]
- Stenehjem, E.; Rimland, D. MRSA nasal colonization burden and risk of MRSA infection. Am. J. Infect. Control 2013, 41, 405–410. [Google Scholar] [CrossRef]
- Boase, S.; Foreman, A.; Cleland, E.; Tan, L.; Melton-Kreft, R.; Pant, H.; Hu, F.Z.; Ehrlich, G.D.; Wormald, P.-J. The microbiome of chronic rhinosinusitis: Culture, molecular diagnostics and biofilm detection. BMC Infect. Dis. 2013, 13, 210. [Google Scholar] [CrossRef]
- Connell, J.T.; Yeo, K.; Bouras, G.; Bassiouni, A.; Fenix, K.; Cooksley, C.; Vreugde, S.; Wormald, P.J.; Psaltis, A.J. Enhanced phylogenetic insights into the microbiome of chronic rhinosinusitis through the novel application of long read 16S rRNA gene amplicon sequencing. Rhinology 2024, 62, 152–162. [Google Scholar] [CrossRef]
- Rapoport, S.K.; Smith, A.J.; Bergman, M.; Scriven, K.A.; Brook, I.; Mikula, S.K. Determining the utility of standard hospital microbiology testing: Comparing standard microbiology cultures with DNA sequence analysis in patients with chronic sinusitis. World J. Otorhinolaryngol. Head Neck Surg. 2019, 5, 82–87. [Google Scholar] [CrossRef]
- Hashemia, F.; Hashemian, F.; Bakhshaei, M. The prevalence of positive fungal cultures in patients with chronic rhinosinusitis in a high altitude region of Iran. Iran. J. Otorhinolaryngol. 2012, 24, 29–33. [Google Scholar]
- Montone, K.T. Pathology of Fungal Rhinosinusitis: A Review. Head Neck Pathol. 2016, 10, 40–46. [Google Scholar] [CrossRef]
- Suh, J.D.; Ramakrishnan, V.R.; Tajudeen, B.; Reger, C.; Kennedy, D.W.; Chiu, A.G. Identification and treatment of nontuberculous Mycobacterium sinusitis. Am. J. Rhinol. Allergy 2011, 25, 421–424. [Google Scholar] [CrossRef]
- Rueca, M.; Fontana, A.; Bartolini, B.; Piselli, P.; Mazzarelli, A.; Copetti, M.; Binda, E.; Perri, F.; Gruber, C.E.M.; Nicastri, E.; et al. Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing. Int. J. Environ. Res. Public Health 2021, 18, 2174. [Google Scholar] [CrossRef]
Type of Culture and Isolate Type | Cultures Results (n) | Percentage of Culture Type |
---|---|---|
Bacterial (N = 2012) | ||
Named bacteria identified (positive cultures) | 1142 | 56.8% |
Unnamed bacteria identified * | 79 | 3.9% |
No growth | 183 | 9.1% |
Normal sinus flora | 592 | 29.4% |
Normal oral flora | 16 | 0.8% |
Fungal (N = 287) | ||
No growth | 265 | 92.3% |
Growth without genus result | 19 | 6.6% |
Growth with genus result | 3 | 1.1% |
Mycobacterial (N = 3) | ||
No growth | 3 | 100.0% |
Bacteria Genus | Number of Cultures | Percentage |
---|---|---|
Staphylococcus | 383 | 33.5% * |
Propionibacterium | 145 | 12.7% |
Haemophilus | 101 | 8.8% |
Pseudomonas | 94 | 8.2% |
Streptococcus | 83 | 7.3% |
Klebsiella | 45 | 3.9% |
Prevotella | 41 | 3.6% |
Escherichia | 35 | 3.1% |
Moraxella | 31 | 2.7% |
Serratia | 29 | 2.5% |
Fusobacterium | 26 | 2.3% |
Enterobacter | 24 | 2.1% |
Stenotrophomonas | 17 | 1.5% |
Peptoniphilus/Peptostreptococcus | 15 | 1.3% |
Proteus | 15 | 1.3% |
Citrobacter | 9 | 0.8% |
Corynebacterium | 8 | 0.8% |
Acinetobacter | 6 | 0.5% |
Enterococcus | 6 | 0.5% |
Staphylococcus Species | Number of Cultures | Percentage |
---|---|---|
Staphylococcus aureus—MSSA | 311 | 81.2% |
Staphylococcus aureus—MRSA | 42 | 11.0% |
Staphylococcus epidermidis | 6 | 1.6% |
Staphylococcus lugdenesis | 3 | 0.8% |
Staphylococcus intermedius | 3 | 0.8% |
Staphylococcus cohnii | 1 | 0.3% |
Staphylococcus saprophyticus | 1 | 0.3% |
Staphylococcus, not speciated | 58 | 15.1% |
Bacteria Genus and Species | Number of Cultures | Percentage within Genus |
---|---|---|
Propionibacterium | 145 | |
Propionibacterium acnes | 132 | 91.0% |
Propionibacterium granulosum | 13 | 9.0% |
Haemophilus | 101 | |
Haemophilus influenzae | 88 | 87.1% |
Haemophilus, not speciated | 13 | 12.8% |
Pseudomonas | 94 | |
Pseudomonas aeruginosa | 92 | 97.8% |
Pseudomonas stutzeri | 1 | 1.1% |
Pseudomonas, not speciated | 1 | 1.1% |
Streptococcus | 83 | |
Streptococcus pneumoniae | 46 | 55.4% |
Streptococcus intermedius | 2 | 2.2% |
Streptococcus pyogenes | 1 | 1.2% |
Streptococcus, not speciated | 35 | 42.2% |
Klebsiella | 45 | |
Klebsiella oxytoca | 22 | 48.9% |
Klebsiella pneumonaie | 21 | 46.7% |
Klebsiella ozaenae | 1 | 2.2% |
Prevotella | 41 | |
Prevotella oralis | 10 | 24.3% |
Prevotella melaninogenica | 7 | 17.1% |
Prevotella loescheii | 5 | 12.2% |
Prevotella intermedia | 4 | 9.8% |
Prevotella oris | 4 | 9.8% |
Prevotella denticola | 3 | 7.3% |
Prevotella bivia | 3 | 7.3% |
Prevotella buccae | 2 | 4.9% |
Prevotella, not speciated | 3 | 7.3% |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mitchell, M.B.; Workman, A.D.; Lu, R.; Bhattacharyya, N. Contemporary Update on the Microbiology of Paranasal Sinusitis. Sinusitis 2024, 8, 13-19. https://doi.org/10.3390/sinusitis8020003
Mitchell MB, Workman AD, Lu R, Bhattacharyya N. Contemporary Update on the Microbiology of Paranasal Sinusitis. Sinusitis. 2024; 8(2):13-19. https://doi.org/10.3390/sinusitis8020003
Chicago/Turabian StyleMitchell, Margaret B., Alan D. Workman, Richard Lu, and Neil Bhattacharyya. 2024. "Contemporary Update on the Microbiology of Paranasal Sinusitis" Sinusitis 8, no. 2: 13-19. https://doi.org/10.3390/sinusitis8020003
APA StyleMitchell, M. B., Workman, A. D., Lu, R., & Bhattacharyya, N. (2024). Contemporary Update on the Microbiology of Paranasal Sinusitis. Sinusitis, 8(2), 13-19. https://doi.org/10.3390/sinusitis8020003